Abstract

Nelson’s syndrome is an infrequent pituitary mass with an incidence of 8–43% in adults and 25–66% in children that develops following total bilateral adrenalectomy (TBA) for the treatment of Cushing’s disease. It is one of the most challenging of all endocrine conditions. The frequent aggressiveness of the underlying ACTH-secreting pituitary adenoma (corticotrophinoma) necessitates regular biochemical and radiological screening. Current evidence favours a lack of prophylactic neoadjuvant pituitary radiotherapy at the time of TBA and a rapid rise of ACTH levels in the year post TBA as factors that may predict the occurrence of Nelson’s syndrome. Though, computerized tomography (CT)/magnetic resonance imaging (MRI) have led to the early diagnosis and improvement in management. Nelson’s related tumours are sometimes detected late, through clinical manifestations of invasion and compression of the surrounding structures. With this perspective in mind, we describe a 22 year old gentleman 10 years after TBA who presented with right sided hemiparesis due to a corticotroph adenoma.

Highlights

  • Key terms: Nelson syndrome, radiotherapy, bilateral adrenalectomy

  • Nelson’s syndrome is an infrequent pituitary mass that develops following total bilateral adrenalectomy (TBA) for the treatment of Cushing’s disease

  • Current evidence suggests risk factors that include a lack of prophylactic neoadjuvant pituitary radiotherapy at the time of TBA and a rapid rise of adrenocorticotropic hormone (ACTH) levels in the first year post TBA as factors that may predict the occurrence of Nelson’s syndrome

Read more

Summary

Introduction

Key terms: Nelson syndrome, radiotherapy, bilateral adrenalectomy Nelson’s syndrome is an infrequent pituitary mass that develops following total bilateral adrenalectomy (TBA) for the treatment of Cushing’s disease. In 1958, Don Nelson described the first case in a 33-year-old woman who had undergone total bilateral adrenalectomy (TBA) for the treatment of refractory Cushing’s disease.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.